MedPath
NMPA Product

Sulfadiazine Suspension

Product approved by National Medical Products Administration (CN)

Basic Information

Sulfadiazine Suspension

磺胺二甲嘧啶混悬液

10%

口服混悬剂

Regulatory Information

国药准字H20056260

Approved

化学药品

July 6, 2015

Company Information

Active Ingredients

© Copyright 2025. All Rights Reserved by MedPath